ACOR
Income statement / Annual
Last year (2023), Acorda Therapeutics, Inc.'s total revenue was $117.63 M,
a decrease of 0.79% from the previous year.
In 2023, Acorda Therapeutics, Inc.'s net income was -$252.85 M.
See Acorda Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$117.63 M
|
$118.57 M
|
$129.07 M
|
$152.97 M
|
$192.41 M
|
$471.43 M
|
$588.29 M
|
$519.60 M
|
$492.66 M
|
$401.48 M
|
| Cost of Revenue |
$46.05 M |
$30.33 M |
$40.79 M |
$33.51 M |
$34.85 M |
$99.31 M |
$135.71 M |
$108.11 M |
$92.93 M |
$80.62 M |
| Gross Profit |
$71.59 M |
$88.23 M |
$88.28 M |
$119.45 M |
$157.56 M |
$372.12 M |
$452.57 M |
$411.49 M |
$399.73 M |
$320.87 M |
| Gross Profit Ratio |
0.61 |
0.74 |
0.68 |
0.78 |
0.82 |
0.79 |
0.77 |
0.79 |
0.81 |
0.8 |
| Research and Development
Expenses |
$5.15 M
|
$5.80 M
|
$10.42 M
|
$23.01 M
|
$60.08 M
|
$106.38 M
|
$166.11 M
|
$203.44 M
|
$149.21 M
|
$73.47 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$172.25 M
|
$181.62 M
|
$235.44 M
|
$205.63 M
|
$201.81 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$320,000.00
|
-$17.55 M
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$89.70 M
|
$106.26 M
|
$124.40 M
|
$152.58 M
|
$192.85 M
|
$172.25 M
|
$181.30 M
|
$217.89 M
|
$205.63 M
|
$201.81 M
|
| Other Expenses |
$51,000.00 |
$18.21 M |
$30.76 M |
$30.76 M |
$25.64 M |
-$18.06 M |
-$19.07 M |
-$6.29 M |
-$14.62 M |
-$8.38 M |
| Operating Expenses |
$94.85 M |
$130.27 M |
$165.58 M |
$206.35 M |
$278.56 M |
$278.64 M |
$347.40 M |
$421.32 M |
$354.84 M |
$275.28 M |
| Cost And Expenses |
$140.90 M |
$160.60 M |
$206.37 M |
$239.86 M |
$313.41 M |
$377.95 M |
$483.12 M |
$529.43 M |
$447.77 M |
$355.90 M |
| Interest Income |
$530,000.00 |
$1.91 M |
$5,000.00 |
$816,000.00 |
$4.17 M |
$3.52 M |
$136,000.00 |
$339,000.00 |
$440,000.00 |
$674,000.00 |
| Interest Expense |
$31.53 M |
$28.29 M |
$30.04 M |
$30.57 M |
$21.87 M |
$21.60 M |
$18.66 M |
$16.53 M |
$15.47 M |
$9.29 M |
| Depreciation &
Amortization |
$31.67 M
|
$32.01 M
|
$32.50 M
|
$21.94 M
|
$25.64 M
|
$11.48 M
|
$23.23 M
|
$21.58 M
|
$15.01 M
|
$8.47 M
|
| EBITDA |
$8.40 M
|
-$10.03 M
|
-$44.80 M
|
-$64.96 M
|
$40.18 M
|
$148.49 M
|
$443.15 M
|
$16.32 M
|
$55.79 M
|
$54.77 M
|
| EBITDA Ratio |
0.07 |
-0.08 |
-0.35 |
-0.42 |
0.21 |
0.31 |
0.75 |
0.03 |
0.11 |
0.14 |
| Operating Income Ratio
|
-0.2
|
-0.35
|
-0.6
|
-0.57
|
0.08
|
0.08
|
-0.4
|
-0.07
|
0.07
|
0.09
|
| Total Other
Income/Expenses Net |
-$272.76 M
|
$6.54 M
|
-$15.15 M
|
-$1.46 M
|
-$157.64 M
|
-$18.06 M
|
-$19.07 M
|
-$32.49 M
|
-$14.62 M
|
-$8.38 M
|
| Income Before Tax |
-$296.02 M |
-$35.25 M |
-$109.07 M |
-$107.67 M |
-$274.25 M |
$20.42 M |
-$251.89 M |
-$42.27 M |
$19.37 M |
$28.01 M |
| Income Before Tax Ratio
|
-2.52
|
-0.3
|
-0.85
|
-0.7
|
-1.43
|
0.04
|
-0.43
|
-0.08
|
0.04
|
0.07
|
| Income Tax Expense |
-$43.17 M |
$30.67 M |
-$5.12 M |
-$8.07 M |
-$1.28 M |
-$13.26 M |
-$28.53 M |
-$6.67 M |
$8.31 M |
$10.34 M |
| Net Income |
-$252.85 M |
-$65.92 M |
-$103.95 M |
-$99.59 M |
-$272.97 M |
$33.68 M |
-$223.36 M |
-$34.62 M |
$11.06 M |
$17.67 M |
| Net Income Ratio |
-2.15 |
-0.56 |
-0.81 |
-0.65 |
-1.42 |
0.07 |
-0.38 |
-0.07 |
0.02 |
0.04 |
| EPS |
-203.59 |
-66.9 |
-195.75 |
-246.4 |
-689.42 |
85.98 |
-582.69 |
-91.79 |
31.42 |
51.53 |
| EPS Diluted |
-203.59 |
-66.9 |
-195.75 |
-246.4 |
-689.42 |
85.38 |
-583.2 |
-91.79 |
30 |
50.4 |
| Weighted Average Shares
Out |
$1.24 M
|
$985,350.00
|
$531,050.00
|
$404,199.00
|
$395,933.00
|
$391,750.00
|
$382,988.00
|
$377,158.00
|
$363,508.00
|
$350,634.00
|
| Weighted Average Shares
Out Diluted |
$1.24 M
|
$985,350.00
|
$531,050.00
|
$404,199.00
|
$395,933.00
|
$394,508.00
|
$383,325.00
|
$377,158.00
|
$368,600.00
|
$354,533.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
